We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Drugs for treating diseases.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Drugs for treating diseases - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Drugs for treating diseases Product List

1～25 item / All 25 items

Displayed results
Tohoku Univ. Technology :PPARα agonists that improve cognitive function: T22-091

Tohoku Univ. Technology :PPARα agonists that improve cognitive function: T22-091

New drug discovery seeds for psychiatric disorders such as schizophrenia

Recent large-scale genomic and postmortem brain analyses have indicated that synaptic dysgenesis may be involved in the pathogenesis of schizophrenia, but the detailed mechanisms remain unclear. Drugs mainly blocking dopamine D2 receptors have been used for the treatment of schizophrenia, but they are mainly used for symptomatic treatment and have insufficient effects on negative symptoms and cognitive dysfunction. Therefore, it is desirable to develop new drugs based on new molecular mechanisms.　 　The inventors have discovered that the decreased function of the PPARA gene, which encodes the nuclear receptor PPARα, is involved in the pathogenesis of schizophrenia [1]. Since PPARα is a transcription factor that can be activated by its ligand, they considered the possibility that activation of PPARA might lead to the improvement of schizophrenia, and found that fenofibrate, a PPARa agonist, is actually effective in improving synaptic function [2]. In this study, they found that pemafibrate, a PPARa agonist, helps to improve cognitive function at the same time as restoring spine density in mice. The invention could lead to the discovery of novel mechanisms for schizophrenia. Furthermore, since decreased spine density and cognitive decline are similar symptoms in other psychiatric disorders such as Alzheimer's, it could also be a therapeutic agent for these disorders.

  • others
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tohoku University Technology: Candidate of therapeutic drug for muscular dystrophy: T16-108

Tohoku University Technology: Candidate of therapeutic drug for muscular dystrophy: T16-108

Metformin helps to repair skeletal muscle!

During sarcolemma repair process, dysferlin protein accumulates at injury part. Dysferlin gene mutation is found in dysferlinopathy, which is a type of muscular dystrophy. Inventors have shown that AMPK, which regulates energy metabolism, binds membrane repair protein dysferlin. Administration of metformin, one of the AMPK activator, improves cell membrane repair in dysferlinopathy.　 　This invention proposes to use metformin, well known therapeutic drug for diabete, as an activator of sarcolemma repair, and to use it as a therapeutic drug for muscular disease such as muscular dystrophy and various diseases that present cell membrane fragility. Features・Outstandings

  • others
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Respiratory Disease Treatment Drugs

[Research Material] Global Market for Respiratory Disease Treatment Drugs

Global Market for Respiratory Disease Treatment Drugs: Oral, Nasal, Injectable, Hospitals, Pharmacies

This research report (Global Respiratory Disorders Drugs Market) investigates and analyzes the current state and outlook for the global market for respiratory disease treatment drugs over the next five years. It includes information on the overview of the global respiratory disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include oral, nasal, and injectable forms, while the segments by application focus on hospitals and pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for respiratory disease treatment drugs. It also includes the market share of major companies in the respiratory disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease

[Research Material] The Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease

Global Market for Treatment of Autosomal Dominant Polycystic Kidney Disease: Pain and Inflammation Treatment, Kidney Stone Treatment, Urinary Tract Infection Treatment, Renal Failure Treatment, Others, Hospitals, Clinics ...

This research report (Global Autosomal Dominant Polycystic Kidney Disease) investigates and analyzes the current status and outlook for the global market for autosomal dominant polycystic kidney disease treatment over the next five years. It includes information on the overview of the global autosomal dominant polycystic kidney disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include pain and inflammation treatment, kidney stone treatment, urinary tract infection treatment, renal failure treatment, and others, while the segments by application include hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for autosomal dominant polycystic kidney disease treatment. It also includes the market share of major companies in the autosomal dominant polycystic kidney disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Treatments

[Research Material] Global Market for Rare Disease Treatments

Global Market for Rare Disease Treatments: Originator Drugs, Generic Drugs, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies

This research report (Global Rare Disease Treatment Market) investigates and analyzes the current state of the global market for rare disease treatments and its outlook for the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare disease treatment market focus on originator drugs and generic drugs, while the segments by application target hospital pharmacies, specialty pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. It also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

World Market for Treatment of Acquired Cystic Kidney Disease: Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Others, Hospitals, Clinics, Research Institutions, Others

This research report (Global Acquired Cystic Kidney Disease Treatment Dr) investigates and analyzes the current status and outlook for the global market of acquired cystic kidney disease treatment drugs over the next five years. It includes information on the overview of the global acquired cystic kidney disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antibiotics, non-steroidal anti-inflammatory drugs, and others, while the segments by application focus on hospitals, clinics, research institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acquired cystic kidney disease treatment drugs. It also includes the market share of major companies in the acquired cystic kidney disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Neurodegenerative Disease Treatments

[Research Material] Global Market for Neurodegenerative Disease Treatments

Global Market for Neurodegenerative Disease Treatments: Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others, Multiple Sclerosis ...

This research report (Global Neurodegenerative Disorder Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for neurodegenerative disease therapeutics over the next five years. It includes information on the overview of the global neurodegenerative disease therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunomodulators, interferons, decarboxylase inhibitors, dopamine agonists, and others, while the segments by application focus on multiple sclerosis, Parkinson's disease, Alzheimer's disease, spinal muscular atrophy, Huntington's disease, and other neurodegenerative diseases. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for neurodegenerative disease therapeutics. The report also includes the market share of major companies in neurodegenerative disease therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Autoimmune Disease Treatments

[Research Material] Global Market for Autoimmune Disease Treatments

Global Market for Autoimmune Disease Treatments: Immunosuppressants, Anti-inflammatory Drugs, Corticosteroids, Non-steroidal Anti-inflammatory Drugs, Biologics, Others, Hospitals, ...

This research report (Global Autoimmune Disease Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for autoimmune disease therapeutics over the next five years. It includes information on the overview of the global autoimmune disease therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunosuppressants, anti-inflammatory drugs, corticosteroids, non-steroidal anti-inflammatory drugs, biologics, and others, while the segments by application focus on hospitals, clinics, independent pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for autoimmune disease therapeutics. The report also includes the market share of major companies in the autoimmune disease therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Orphan Lung Diseases

[Research Material] Global Market for Treatment of Orphan Lung Diseases

Global Market for Orphan Lung Disease Treatments: Immunosuppressants, Anti-inflammatory Drugs, Antifibrotic Agents, Vasodilators, Corticosteroids, CFTR Modulators, and others...

This research report (Global Orphan Lung Diseases Treatment Market) investigates and analyzes the current status and outlook for the global orphan lung diseases treatment market over the next five years. It includes information on the overview of the global orphan lung diseases treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the orphan lung diseases treatment market include immunosuppressants, anti-inflammatory drugs, anti-fibrotic drugs, vasodilators, corticosteroids, CFTR modulators, and others. The segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for orphan lung diseases treatment. It also includes the market share of major companies in orphan lung diseases treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Swine Respiratory Disease Treatment

[Research Material] The Global Market for Swine Respiratory Disease Treatment

Global Market for Swine Respiratory Disease Treatment: Viruses, Bacteria, Mycoplasma, Parasites, Others, Pharmacies, Veterinary Hospitals, Clinics, Others

This research report (Global Swine Respiratory Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for swine respiratory disease treatment over the next five years. It includes information on the overview of the global swine respiratory disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the swine respiratory disease treatment market target viruses, bacteria, mycoplasma, parasites, and others, while the segments by application focus on pharmacies, veterinary hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for swine respiratory disease treatment. It also includes the market share of major companies in swine respiratory disease treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Alcoholic Liver Disease Treatment

[Research Material] The Global Market for Alcoholic Liver Disease Treatment

Global Market for Alcoholic Liver Disease Treatment: Alcoholic Fatty Liver Disease, Alcoholic Hepatitis, Others, Hospital Pharmacies, Retail Pharmacies, Drugstores ...

This research report (Global Alcoholic Liver Diseases Treatment Market) investigates and analyzes the current status and outlook for the global market for alcoholic liver disease treatment over the next five years. It includes information on the overview of the global alcoholic liver disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the alcoholic liver disease treatment market include alcoholic fatty liver disease, alcoholic hepatitis, and others, while the segments by application include hospital pharmacies, retail pharmacies, drugstores, online pharmacies, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for alcoholic liver disease treatment. It also includes the market share of major companies in the alcoholic liver disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Neurological Disease Treatments

[Research Material] Global Market for Rare Neurological Disease Treatments

Global Market for Rare Neurological Disease Treatments: Biologics, Organic Compounds, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Rare Neurological Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for rare neurological disease treatments over the next five years. It includes information on the overview of the global rare neurological disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare neurological disease treatment market focus on biopharmaceuticals and organic compounds, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for rare neurological disease treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare neurological disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Morquio Syndrome Treatment

[Research Material] The Global Market for Morquio Syndrome Treatment

Global Market for Morquio Syndrome Treatment: Morquio A, Morquio B, Hospitals, Clinics, Others

This research report (Global Morquio Syndrome Treatment Market) investigates and analyzes the current state and future outlook of the global market for Morquio syndrome treatment over the next five years. It includes information on the overview of the global Morquio syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on Morquio A and Morquio B, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Morquio syndrome treatment. It also includes the market share of major companies in Morquio syndrome treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Rare Neurodegenerative Diseases

[Research Material] Global Market for Treatments of Rare Neurodegenerative Diseases

Global Market for Rare Neurodegenerative Disease Treatments: Neurotransmitters, Neuroprotective Agents, Biologics, Others, Amyotrophic Lateral Sclerosis (ALS), Attention Deficit Hyperactivity ...

This research report (Global Rare Neurodegenerative Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for rare neurodegenerative disease treatments over the next five years. It includes information on the overview of the global rare neurodegenerative disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include neurotransmitters, neuroprotective agents, biologics, and others, while the segments by application focus on amyotrophic lateral sclerosis (ALS), attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, Parkinson's disease, and others. The regional segments calculate the market size for rare neurodegenerative disease treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare neurodegenerative disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Women's Health Treatments

[Research Material] Global Market for Women's Health Treatments

Global Market for Women's Health Treatments: Menopause, Endometriosis, Postmenopausal Osteoporosis, Breast Cancer, Polycystic Ovary Syndrome, Infertility, Gynecological Cancers, Diagnostics and Imaging ...

This research report (Global Women Health Therapeutics Market) investigates and analyzes the current state and outlook for the global market for women's health therapeutics over the next five years. It includes information on the overview of the global women's health therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the women's health therapeutics market by type include menopause, endometriosis, postmenopausal osteoporosis, breast cancer, polycystic ovary syndrome, infertility, and gynecological cancers. The segments by application focus on diagnostic and imaging centers, hospitals and clinics, and home care. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for women's health therapeutics. The report also includes the market share of major companies in women's health therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
World Market for Waldenström's Macroglobulinemia Treatment Drugs

World Market for Waldenström's Macroglobulinemia Treatment Drugs

Global Market for Waldenström Macroglobulinemia Treatments: CB-839, Copanlisib Hydrochloride, DI-B4, Entospletinib ...

This research report (Global Waldenstrom Macroglobulinemia Therapeutics Market) investigates and analyzes the current status and outlook for the global market of Waldenstrom macroglobulinemia therapeutics over the next five years. It includes information on the overview of the global Waldenstrom macroglobulinemia therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include CB-839, Copanlisib hydrochloride, DI-B4, Entospletinib, Everolimus, FV-162, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Waldenstrom macroglobulinemia therapeutics.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Disease Therapeutics

[Research Material] Global Market for Rare Disease Therapeutics

World Market for Rare Disease Treatments: Above 1‰, 0.65‰ to 1‰, Below 0.1‰, Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Others

This research report (Global Rare Disease Drug Market) investigates and analyzes the current status and outlook for the global market for rare disease treatments over the next five years. It includes information on the overview of the global rare disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include those with a prevalence of 1‰ or more, 0.65‰ to 1‰, and 0.1‰ or less, while the segments by application focus on hospital pharmacies, specialty pharmacies, retail pharmacies, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for rare disease treatments. The report also includes the market share of major companies in the rare disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Non-Alcoholic Fatty Liver Disease Treatment

[Research Material] Global Market for Non-Alcoholic Fatty Liver Disease Treatment

Global Market for Non-Alcoholic Fatty Liver Disease Treatment: Antioxidants, Thiazolidinediones, Biguanides, Lipid-Lowering Agents, FXR Receptor Agonists, etc.

This research report (Global Non-Alcoholic Fatty Liver Disease Treatment Market) investigates and analyzes the current status and outlook for the global market for non-alcoholic fatty liver disease treatment over the next five years. It includes information on the overview of the global non-alcoholic fatty liver disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the non-alcoholic fatty liver disease treatment market include antioxidants, thiazolidinediones, biguanides, lipid-lowering agents, FXR receptor agonists, and others. The segments by application include hospital pharmacies, retail pharmacies, drugstores, online pharmacies, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for non-alcoholic fatty liver disease treatment. It also includes the market share of major companies in the non-alcoholic fatty liver disease treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Lipid Metabolism Disease Treatment

[Research Material] Global Market for Lipid Metabolism Disease Treatment

Global Market for Lipid Metabolism Disorder Treatments: OTC, Prescription Drugs, Hospitals, Retail Pharmacies

This research report (Global Lipid Metabolism Disease Treatment Market) investigates and analyzes the current state and outlook for the global lipid metabolism disease treatment market over the next five years. It includes information on the overview of the global lipid metabolism disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the lipid metabolism disease treatment market focus on OTC and prescription drugs, while the segments by application target hospitals and retail pharmacies. The regional segments calculate the market size for lipid metabolism disease treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in lipid metabolism disease treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Neurological Disease Treatment Drugs

[Research Material] Global Market for Neurological Disease Treatment Drugs

Global Market for Neurological Disorder Treatments: Central Nervous System (CNS), Peripheral Nervous System (PNS), paralysis, muscle weakness, coordination disorders, sensory loss, seizures, confusion ...

This research report (Global Neurologic Disorders Therapeutics Market) investigates and analyzes the current state and outlook for the global market of neurologic disorder therapeutics over the next five years. It includes information on the overview of the global neurologic disorder therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the neurologic disorder therapeutics market focus on the central nervous system (CNS) and peripheral nervous system (PNS), while the segments by application target paralysis, muscle weakness, coordination disorders, sensory loss, seizures, confusion, pain, and changes in consciousness levels. The regional segments calculate the market size for neurologic disorder therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in neurologic disorder therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Joint Disease Treatment Drugs

[Research Material] Global Market for Joint Disease Treatment Drugs

Global Market for Joint Disease Treatment Drugs: Pharmacotherapy, Rehabilitation, Surgery, Hospitals, Clinics, Others

This research report (Global Joint Disease Therapeutics Market) investigates and analyzes the current state and outlook for the global market for joint disease therapeutics over the next five years. It includes information on the overview of the global joint disease therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include drug therapy, rehabilitation, and surgery, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for joint disease therapeutics. It also includes the market share of major companies in joint disease therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cardiovascular Disease Treatment Drugs

[Research Material] Global Market for Cardiovascular Disease Treatment Drugs

World Market for Cardiovascular Disease Treatments: Heparin, Coumadin, Sectral, Zebeta, Lopressor, Toprol-XL, Norvasc, Lot...

This research report (Global Cardiovascular Disease Drugs Market) investigates and analyzes the current state and outlook for the global market of cardiovascular disease treatment drugs over the next five years. It includes information on the overview of the global cardiovascular disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include heparin, coumadin, sectral, zebeta, lopressor, toprol-XL, norvasc, lotrel, and others, while the segments by application cover ischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery disease, peripheral artery disease, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for cardiovascular disease treatment drugs. It also includes the market share of major companies in the cardiovascular disease treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Drug Treatment of Metastatic Bone Diseases

[Research Material] The Global Market for Drug Treatment of Metastatic Bone Diseases

Global Market for Drug Treatment of Metastatic Bone Diseases: Chemotherapy, Hormonal Therapy, Bisphosphonates, Opioid Therapy, Immunotherapy, Hospitals, Clinics, Others

This research report (Global Medication Treatment of Metastatic Bone Disease) investigates and analyzes the current state and outlook for the global market of metastatic bone disease drug treatment over the next five years. It includes information on the overview of the global metastatic bone disease drug treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the metastatic bone disease drug treatment market include chemotherapy, hormone therapy, bisphosphonates, opioid therapy, and immunotherapy, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for metastatic bone disease drug treatment. The report also includes the market share of major companies in metastatic bone disease drug treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Bovine Respiratory Disease Treatment

[Research Material] Global Market for Bovine Respiratory Disease Treatment

Global Market for Bovine Respiratory Disease Treatment: Vaccines, Antibiotics, Immunomodulators, Others, Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Private Veterinary Pharmacies

This research report (Global Bovine Respiratory Disease Treatment Market) investigates and analyzes the current state and outlook for the global bovine respiratory disease treatment market over the next five years. It includes information on the overview of the global bovine respiratory disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the bovine respiratory disease treatment market include vaccines, antibiotics, immunomodulators, and others, while the segments by application focus on veterinary clinics, veterinary hospitals, veterinary research institutes, and private veterinary pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for bovine respiratory disease treatment. It also includes the market share of major companies in bovine respiratory disease treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Inflammatory Bowel Disease Treatment Market

[Market Report] Global Inflammatory Bowel Disease Treatment Market

The global inflammatory bowel disease treatment market is expected to achieve steady growth, reaching 34 billion USD by 2031.

The global inflammatory bowel disease (IBD) treatment market is on an upward trajectory, with revenues reaching approximately $22 billion in 2022, and an estimated value of $34 billion by 2031. This significant growth is projected to occur at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2023 to 2031. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation of the gastrointestinal tract. It primarily consists of two distinct conditions: Crohn's disease and ulcerative colitis. Crohn's disease is known for causing inflammation and discomfort in various parts of the gastrointestinal tract, often affecting the small intestine and the upper part of the large intestine. On the other hand, ulcerative colitis primarily causes pain and inflammation in the colon. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • Drugs for treating diseases

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Drugs for treating diseases

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.